Definitive Contract HHSN261201400013C

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, was awarded a Blanket Purchase Agreement (BPA) call valued at $3,201.80 by the National Institute of Neurological Disorders and Stroke (NINDS) on February 4, 2013, with an ultimate completion date of August 31, 2013. The contract utilized firm fixed pricing and was not designated as a set-aside purchase, indicating open...

The Office of the Assistant Secretary for Preparedness and Response awarded a $300 million definitive contract to Trustees of Boston University for the CARB-X Global Antibacterial Accelerator OTA on June 1, 2022, under a cost-no-fee pricing structure with an ultimate completion date of May 31, 2032. The contract operates as an Other Transaction Agreement (OTA) with no set-aside designation. Place of performance is Boston, MA. The originating solicitation describes a Broad Agency Announcement...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $21,418.90 firm fixed-price call against a Blanket Purchase Agreement (BPA) by the National Center for Advancing Translational Sciences on June 24, 2014. The contract covers the supply of a custom TrocrIScreen compound library consisting of 594 compounds at 5 milligrams each, to be delivered by August 31, 2014. This award was made through open competition with no...

The Food and Drug Administration (FDA) awarded a $47.1 million firm fixed-price definitive contract to Deloitte Consulting LLP on September 26, 2022, to develop standards for data quality and data sources that increase the quality, interoperability, and usability of real-world data (DPMWP 217/CDRH-2022-112765). The contract, which originated from the FDA's Broad Agency Announcement for Advanced Regulatory Science, supports the agency's modernization efforts in regulatory science by harnessing...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, was awarded a $14,160 firm fixed-price blanket purchase agreement (BPA) call by the National Institute on Aging on August 5, 2011, with an ultimate completion date of August 31, 2011. The contract, which involved no set-aside designation, covers the procurement of research and diagnostic systems and ELISA kits to support the agency's...

This federal contract is a definitive cost-no-fee biomedical basic research award valued at $8.195 million, with a performance period extending from the September 24, 1993 award date through June 30, 1996. The contract was executed without a set-aside designation and encompasses basic biomedical research activities to be conducted in New York. The cost-no-fee pricing structure indicates that the contractor will be reimbursed for allowable costs incurred in performance of the work with no...

Research and Diagnostic Systems, Inc. (R&D Systems), a subsidiary of Bio-Techne Corporation headquartered in Minneapolis, Minnesota, received a $14,160 firm fixed price Blanket Purchase Agreement (BPA) call award from the National Institute on Aging on July 23, 2012, with an ultimate completion date of July 31, 2012. This non-set-aside contract was awarded through open competition and represents a task order under R&D Systems' existing BPA for the provision of biological research...

The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to GE Medical Systems Information Technologies, Inc. for development of AI-enabled algorithms to assess head trauma, intracranial pressure, abdominal and lung injuries on September 21, 2023, with a $70.48 million ceiling and cost-sharing pricing. This award carries no set-aside designation and an ultimate completion date of December 31, 2029. The contract funds development of non-invasive...

Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a $6,974.05 firm fixed-price call under a Blanket Purchase Agreement (BPA) by the National Heart, Lung, and Blood Institute (NHLBI) on March 11, 2016. The contract, which utilized no set-aside designation and operated under open competition, was for the supply of recombinant human/mouse/rat Activin A protein, a bioactive reagent commonly used in cardiovascular and...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases to Research And Diagnostic Systems, Inc., doing business as R&D Systems. The firm-fixed-price purchase order, valued at $222,038.00, is for the provision of medical and surgical instruments, equipment, and supplies. R&D Systems is a for-profit manufacturer and global leader in research proteins, antibodies, and...